Treatment strategy for papillary renal cell carcinoma type 2: a case series of seven patients treated based on next generation sequencing data

BACKGROUND: Papillary renal cell carcinoma type 2 (PRCC2) is refractory to systemic treatment and has a dismal prognosis. Previous studies showed that genetic alterations in PRCC2 were heterogeneous regardless of germline or somatic mutations. In this study, we aimed to perform precision treatment o...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Ji-Yeon, Jeong, Hyoung-Oh, Heo, Dae Seog, Keam, Bhumsuk, Moon, Kyung Chul, Kwak, Cheol, Jang, Jinho, Kim, Seunghoon, Kim, Jong-Il, Lee, Semin, Lee, Se-Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723617/
https://www.ncbi.nlm.nih.gov/pubmed/33313134
http://dx.doi.org/10.21037/atm-20-3466

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723617/
https://www.ncbi.nlm.nih.gov/pubmed/33313134
http://dx.doi.org/10.21037/atm-20-3466

Ejemplares similares